Company Filing History:
1 out of 3 
1 out of 1 Years Active: 2025
Title: Masayuki Fujino: Innovator in Antibody Drug Enhancement
Introduction
Masayuki Fujino is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in enhancing the efficacy of antibody drugs. His innovative work focuses on improving treatments for cancer through immune checkpoint inhibitors.
Latest Patents
Fujino holds a patent for a composition aimed at enhancing the effect of antibody drugs. This composition utilizes β-glucan as an active ingredient, which is effective in boosting the performance of antibody drugs that suppress cancer growth via immune checkpoint inhibition. His patent is particularly relevant for monoclonal antibodies targeting PD-L1.
Career Highlights
Throughout his career, Masayuki Fujino has worked with various organizations, including Aureo Co., Ltd. and the National Center for Health and Development. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of antibody drug enhancement.
Collaborations
Fujino has collaborated with notable colleagues such as Ko Rii and Yukiko Moriya. Their combined expertise has contributed to the advancement of research in antibody drug efficacy.
Conclusion
Masayuki Fujino's work in enhancing antibody drugs represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.